Earnings Feed
Start Free
Home/Filings/4/0001179110-17-010388
4//SEC Filing

New York & Company, Inc. 4

Accession 0001179110-17-010388

CIK 0001211351operating
View on SEC.govCompany Profile

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 5:22 PM ET

Size

22.5 KB

Accession

0001179110-17-010388

Insider Transaction Report

Form 4
Period: 2017-06-29
New York & Company, Inc.NWY
Bradley Faeth
EVP, Human Resources
Transactions
  • Award

    Stock Appreciation Rights

    2017-06-29+37,502→ 37,502 total
    Exercise: $1.36Exp: 2023-08-26→ Common Stock (37,502 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−100,000→ 0 total
    Exercise: $2.77Exp: 2021-12-27→ Common Stock (100,000 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+64,286→ 64,286 total
    Exercise: $1.36Exp: 2021-12-27→ Common Stock (64,286 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−67,050→ 0 total
    Exercise: $5.32Exp: 2023-08-26→ Common Stock (67,050 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+51,578→ 51,578 total
    Exercise: $1.36Exp: 2024-08-25→ Common Stock (51,578 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−136,231→ 0 total
    Exercise: $2.60Exp: 2025-08-25→ Common Stock (136,231 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+83,496→ 83,496 total
    Exercise: $1.36Exp: 2025-08-25→ Common Stock (83,496 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−114,618→ 0 total
    Exercise: $3.47Exp: 2024-08-25→ Common Stock (114,618 underlying)
Footnotes (10)
  • [F1]Each Stock Appreciation Right (SAR) represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
  • [F10]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 20,874 on August 25, 2017, 20,873 on June 29, 2018, and 41,749 on August 25, 2018.
  • [F2]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program as more fully described in the Schedule TO, filed with the Securities and Exchange Commission on June 1, 2017. The reporting person was previously awarded SARs which were exercisable as follows: 25,000 on December 27, 2012, 25,000 on December 27, 2013, 25,000 on December 27, 2014, and 25,000 on December 27, 2015.
  • [F3]In exchange for each cancelled award pursuant to the Company's Stock Appreciation Right and Option Exchange Program, the reporting person received a replacement award for a lesser number of SARs with an equal fair value and an exercise price equal to the closing price of the Company's common stock as reported on the New York Stock Exchange on June 29, 2017.
  • [F4]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which all vest on June 29, 2018.
  • [F5]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 16,762 on August 26, 2014, 16,762 on August 26, 2015, and 33,526 on August 26, 2016.
  • [F6]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which all vest on June 29, 2018.
  • [F7]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 28,654 on August 25, 2015, 28,654 on August 25, 2016, and 57,310 on August 25, 2017.
  • [F8]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 25,790 on August 25, 2017 and 25,788 on June 29, 2018.
  • [F9]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 34,057 on August 25, 2016, 34,057 on August 25, 2017, and 68,117 on August 25, 2018.

Documents

1 file

Issuer

New York & Company, Inc.

CIK 0001211351

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001211351

Filing Metadata

Form type
4
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 5:22 PM ET
Size
22.5 KB
View on SEC.gov